In breast cancer, overexpression of AIM2 can decrease the expression of the anti-apoptotic protein Bcl-xl, increase the expression of the pro-apoptotic Bax, and induce the cleavage of the DNA repair protein PARP, thus leading to breast cancer cell apoptosis and the inhibition of breast cancer progression (45). Here, BCL2L1 is linked to breast cancer.